What are the three main immediate treatments for hyperkalemia with potential ECG changes?

• A. Sodium bicarbonate alone
• B. Potassium-binding resin with dialysis
• C. Calcium gluconate, insulin with glucose, and beta-agonist therapy (albuterol)
• D. Calcium chloride and hypertonic saline

Answer: (C)

The key idea is to act quickly to protect the heart and rapidly reduce the amount of potassium available in the bloodstream. The immediate trio that accomplishes this is calcium to stabilize cardiac membranes, followed by shifting potassium into cells with insulin (plus glucose to prevent hypoglycemia), and with a beta-agonist such as albuterol to further promote cellular uptake of potassium.

Calcium gluconate provides rapid membrane stabilization, which lowers the risk of life-threatening ECG changes and arrhythmias even before potassium levels drop. Insulin with glucose drives potassium from the bloodstream into cells, reducing serum potassium quickly. A beta-agonist like albuterol also pushes potassium into cells, providing an additional rapid drop in serum potassium. Together, these actions address the urgent needs: protect the heart and rapidly lower circulating potassium.

Other approaches, such as potassium-binding resins with dialysis, address total body potassium more slowly and are not immediate. Using bicarbonate alone may help in specific contexts (like acidosis) but does not reliably achieve a rapid potassium drop. Calcium chloride can be used in some protocols, but it is more tissue-irritating, and hypertonic saline is not a standard immediate treatment for hyperkalemia. The combination of calcium gluconate, insulin with glucose, and a beta-agonist best fits the urgent needs of hyperkalemia with ECG changes.